Latest Manufacturing Capacity News

Page 3 of 22
Structural Monitoring Systems (ASX:SMN) delivered record FY26 revenue, a sharp lift in profit and $6.0 million of free cash flow as its avionics business outpaced contract manufacturing. The balance sheet is now free of bank debt, but the next leg of the story still depends on FAA approvals and converting CVM technology into commercial revenue.
Victor Sage
Victor Sage
29 Sept 2026
Mesoblast has secured FDA approval to add a new potency assay to commercial release and stability testing for Ryoncil, its approved cell therapy for paediatric graft-versus-host disease. The regulatory decision supports tighter monitoring as manufacturing processes evolve, but the company disclosed no direct financial impact or clinical outcome data.
Ada Torres
Ada Torres
24 Sept 2026
Waterco Limited (ASX:WAT) delivered record FY26 EBIT of $23.8 million and lifted net profit after tax 59.6% to $15.4 million, despite only modest revenue growth. The stronger result supports a higher fully franked dividend, but the group is carrying more debt and inventory as it expands manufacturing capacity.
Victor Sage
Victor Sage
21 Sept 2026
Innovaero Technologies is seeking A$40 million through a proposed ASX listing to advance its OWL loitering munition program and expand manufacturing capacity. The replacement prospectus also makes clear that the company remains loss-making and heavily dependent on the Department of Defence converting development work into production orders.
Victor Sage
Victor Sage
18 Sept 2026
PolyNovo delivered 16.1% revenue growth and a sharp improvement in operating cash flow in FY26, despite a lower statutory profit after a prior-year tax benefit and a fire-related write-off. The ASX-listed wound-care company now expects to lodge its U.S. PMA application for NovoSorb BTM before the end of 2026.
Victor Sage
Victor Sage
15 Sept 2026
Green360 Technologies says more than 3,500 cubic metres of concrete containing its MKX metakaolin product has now been used across major Melbourne infrastructure projects. The milestone gives the company a growing field record while it develops demand before committing to dedicated large-scale production.
Victor Sage
Victor Sage
14 Sept 2026
Telix’s Pixclara has become the first FDA-approved FET-PET imaging drug for glioma, opening a new US diagnostic pathway for adults and children. The approval is commercially significant, but pricing, reimbursement and launch timing remain undisclosed.
Victor Sage
Victor Sage
14 Sept 2026
Phoslock Environmental Technologies has advanced a new range of lanthanum-enhanced phosphorus-binding products showing up to four times the capacity of current offerings, with pilot and manufacturing tests confirming strong performance and low lanthanum release. Field trials are underway, aiming for commercial sales in 2027.
Maxwell Dee
Maxwell Dee
7 Sept 2026
The Calmer Co International Limited has closed a renounceable rights issue, raising $1.82 million before costs with full director participation. The capital will support inventory build, retail expansion with Coles, and ongoing strategic partnerships in kava supply and manufacturing.
Victor Sage
Victor Sage
2 Sept 2026
Titomic has raised A$16.5 million through an institutional placement priced at a 23.5% discount, aiming to scale its Huntsville facility and accelerate US growth. The company also advanced a US$10 million loan application with the Export-Import Bank and appointed aerospace veteran Jim Chilton to its board.
Victor Sage
Victor Sage
2 Sept 2026
Sparc Technologies has made its inaugural commercial delivery of ecosparc®, a graphene additive, to a major coatings manufacturer, underpinning its push to dominate the protective coatings market. The company also launched a discounted Share Purchase Plan to fuel ongoing commercial expansion.
Victor Sage
Victor Sage
1 Sept 2026
Pure Foods Tasmania reports a modest revenue dip but boosts gross profit and margin in FY26, while statutory losses swell due to non-cash accounting adjustments and strategic realignment.
Victor Sage
Victor Sage
31 Aug 2026

Browse the archive

Full archive